KIRLYNXA Trademark

Trademark Overview

On Thursday, August 15, 2013, a trademark application was filed for KIRLYNXA with the United States Patent and Trademark Office. The USPTO has given the KIRLYNXA trademark a serial number of 86039488. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 20, 2017. This trademark is owned by AbbVie Inc.. The KIRLYNXA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
kirlynxa

General Information

Serial Number86039488
Word MarkKIRLYNXA
Filing DateThursday, August 15, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 20, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 23, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbVie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Monday, March 20, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 20, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 22, 2016EXTENSION 5 GRANTED
Tuesday, August 9, 2016EXTENSION 5 FILED
Tuesday, August 9, 2016TEAS EXTENSION RECEIVED
Saturday, February 27, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 26, 2016EXTENSION 4 GRANTED
Tuesday, February 9, 2016EXTENSION 4 FILED
Tuesday, February 9, 2016TEAS EXTENSION RECEIVED
Thursday, August 20, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 19, 2015EXTENSION 3 GRANTED
Monday, August 10, 2015EXTENSION 3 FILED
Monday, August 10, 2015TEAS EXTENSION RECEIVED
Thursday, March 26, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 25, 2015EXTENSION 2 GRANTED
Tuesday, February 10, 2015EXTENSION 2 FILED
Saturday, March 21, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 10, 2015TEAS EXTENSION RECEIVED
Tuesday, August 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 8, 2014EXTENSION 1 GRANTED
Friday, August 8, 2014EXTENSION 1 FILED
Friday, August 8, 2014TEAS EXTENSION RECEIVED
Tuesday, February 11, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 27, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 8, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 8, 2013ASSIGNED TO EXAMINER
Friday, August 23, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 19, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

kirlynxa hormonal dermatological gastrointestinal neurological ophthalmic respiratory psychiatric immune disorders vaccines